SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Mesabi Trust (MSB) trades at a trailing P/E of 4.6. Trailing earnings yield is 21.79%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (4.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (21.79%).
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 21.79% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 86/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MSB
Valuation Multiples
P/E (TTM)4.6
Forward P/EN/A
PEG Ratio0.01
Forward PEGN/A
P/B Ratio0.00
P/S Ratio16.82
EV/EBITDA0.0
Per Share Data
EPS (TTM)$7.11
Book Value / Share$0.00
Revenue / Share$1.94
FCF / Share$0.00
Yields & Fair Value
Earnings Yield21.79%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.65 |
$9.72M |
$8.56M |
88% |
| 2017 |
$0.74 |
$10.89M |
$9.61M |
88.3% |
| 2018 |
$2.55 |
$34.5M |
$33.5M |
97.1% |
| 2019 |
$3.47 |
$47.29M |
$45.56M |
96.3% |
| 2020 |
$2.29 |
$31.99M |
$30.06M |
94% |
| 2021 |
$1.78 |
$25.95M |
$23.41M |
90.2% |
| 2022 |
$5.24 |
$71.46M |
$68.77M |
96.2% |
| 2023 |
$0.41 |
$7.5M |
$5.31M |
70.8% |
| 2024 |
$1.45 |
$22.86M |
$18.98M |
83% |
| 2025 |
$7.11 |
$25.46M |
$93.27M |
366.4% |
